ライフサイエンスコーパス: whole-body imaging

1 nanonap radiolabelling allowed complementary whole-body imaging.

2 penetrate tissue well, IFPs are suitable for whole-body imaging.

3 n and regression of xenografts visualized by whole-body imaging.

4 s visualized directly by gamma-scintigraphic whole-body imaging.

5 entative of clinical studies, in particular, whole-body imaging.

6 after kanamycin treatment were visualized by whole-body imaging.

7 ct after gavage was followed in real-time by whole-body imaging.

8 nearly over a 10-day period as determined by whole-body imaging.

9 amples of these technologic advances include whole-body imaging, 3-dimensional imaging, new scintilla

10 differences in tissue types in, for example, whole-body imaging, a set of tissue homogenates of diffe

11 es transgenic (luciferase) reporter mice and whole-body imaging, allowing noninvasive quantification

12 alization of human tumor-host interaction by whole-body imaging and at the cellular level in fresh an

13 ing visualizes the tumor-host interaction by whole-body imaging and at the cellular level in fresh ti

14 Serial whole-body imaging and blood sampling were performed up

15 Planar whole-body imaging and SPECT/CT were performed from thor

16 vital two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial c

17 Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastas

18 For whole-body imaging, as a measure of radiation exposure t

19 (18)F-MFBG intravenously followed by serial whole-body imaging at 0.5-1, 1-2, and 3-4 after injectio

20 loped, but their limited diffusion precludes whole-body imaging at visceral sites.

21 the course of treatment, noninvasive optical whole-body imaging based on brilliant red fluorescent pr

22 les from involved organs is an obstacle that whole-body imaging can help overcome.

23 Whole-body imaging can provide information across lesion

24 We used RIA, whole body imaging, flow cytometry, and fluorescence imm

25 the heart for 10 min, followed by sequential whole-body imaging for 5 h.

26 These results show the potential use of whole-body imaging for receptor status assessment, parti

27 PET whole body imaging in cancer provides the means to (i) i

28 A method based on repeated whole-body imaging in combination with blood and urinary

29 Early whole-body imaging in conjunction with delayed whole-bod

30 iagnostic sensitivities of (123)I and (131)I whole-body imaging in differentiated thyroid cancer.

31 of HCC recurrence support performing regular whole-body imaging initially every 6 to 12 months and co

32 (18)F-FDG PET is a molecular whole-body imaging modality that is increasingly being u

33 Brighter, red-shifted proteins can make whole-body imaging more sensitive owing to reduced absor

34 For whole-body imaging, nude mice are very appropriate.

35 periments; demonstrated here is MALDI-IMS-MS whole body imaging of rats dosed at 6 mg/kg i.v. with an

36 -ray computed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumo

37 Whole-body imaging of 12 patients, who received 111-185

38 With the exception of liver metastases, whole-body imaging of ER expression with (18)F-FES PET c

39 ein-based imaging technology can be used for whole-body imaging of fluorescent cells on essentially a

40 nal cutaneous recurrence (TxN2bM0) underwent whole-body imaging of glucose metabolism with fluorodeox

41 VEGFR3 to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cell

42 protein offers the potential for noninvasive whole-body imaging of numerous cellular and molecular pr

43 It allows noninvasive, whole-body imaging of the FR.

44 Real-time whole-body imaging of the live animals confirmed improve

45 "stick objectives"), is used for three-color whole-body imaging of the two-color cancer cells interac

46 raphy (PET) reporter genes allow noninvasive whole-body imaging of transplanted cells by detection wi

47 aken advantage of to develop a technology of whole-body imaging of tumors and gene expression in mous

48 All patients underwent whole-body imaging on a PET/CT device 1 h after (18)F-FD

49 Healthy volunteers underwent serial whole-body imaging over an approximately 3-h interval, a

50 On whole-body imaging, P-gp blockade significantly affected

51 l isotope distribution using (18)F-FDG and a whole-body imaging protocol to demonstrate proof-of-prin

52 Whole-body imaging revealed that the cells retained thei

53 vaccination and allogeneic graft rejection, whole body imaging reveals that RA signaling is temporal

54 in as an optimal combination for dual color, whole body imaging studies in model animals.

55 rescent protein-transfected cancer cells and whole-body imaging system.

56 Positron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeo

57 Here, we use whole-body imaging to determine the efficacy and kinetic

58 nical applications, enabling the noninvasive whole-body imaging to localize disease and identificatio

59 tigraphy but was obvious on post-therapeutic whole-body imaging, underscoring the value of post-thera

60 Whole-body imaging was carried out with either a trans-i

61 fter a period of thyroid hormone withdrawal, whole-body imaging was performed approximately 24 and 72

62 of (18)F-FDG were administered and repeated whole-body imaging was performed.

63 vital and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, surv

64 In, for example, whole-body imaging where a diversity of tissue types are

65 etic resonance (MR) imaging and fluorescence whole body imaging, which respectively tracked iron oxid

66 Forty patients underwent baseline whole-body imaging with 99mTc-sulfur colloid and evaluat

67 estaging of oncologic malignancies underwent whole-body imaging with a sequential trimodality PET/CT/

68 ging of non-small cell lung cancer underwent whole-body imaging with a sequential trimodality PET/CT/

69 Whole-body imaging with fluorescent proteins is a powerf

70 (18)F-FDG PET/CT scans (whole-body imaging with low-dose CT) of 24 consecutive p

71 ase I study of 62Cu-PTSM was performed using whole-body imaging with PET in 10 healthy volunteers and

72 Whole-body imaging, with scintimammography and PET, and